nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP3A4—bone cancer	0.695	1	CbGaD
Zolpidem—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00257	0.0456	CbGpPWpGaD
Zolpidem—Tolmetin—PTGS2—bone cancer	0.00247	1	CrCbGaD
Zolpidem—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00194	0.0344	CbGpPWpGaD
Zolpidem—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0014	0.0249	CbGpPWpGaD
Zolpidem—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00108	0.0192	CbGpPWpGaD
Zolpidem—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.001	0.0178	CbGpPWpGaD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000998	0.0177	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000996	0.0177	CbGpPWpGaD
Zolpidem—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000989	0.0175	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000946	0.0168	CbGpPWpGaD
Zolpidem—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000945	0.0167	CbGpPWpGaD
Zolpidem—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000937	0.0166	CbGpPWpGaD
Zolpidem—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000901	0.016	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000845	0.015	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000835	0.0148	CbGpPWpGaD
Zolpidem—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.000716	0.0127	CbGpPWpGaD
Zolpidem—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000706	0.0125	CbGpPWpGaD
Zolpidem—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000683	0.0121	CbGpPWpGaD
Zolpidem—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000677	0.012	CbGpPWpGaD
Zolpidem—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000671	0.0119	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—TUBB4B—bone cancer	0.000666	0.0118	CbGpPWpGaD
Zolpidem—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000654	0.0116	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000652	0.0116	CbGpPWpGaD
Zolpidem—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000651	0.0115	CbGpPWpGaD
Zolpidem—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000618	0.0109	CbGpPWpGaD
Zolpidem—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000614	0.0109	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000604	0.0107	CbGpPWpGaD
Zolpidem—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000589	0.0104	CbGpPWpGaD
Zolpidem—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000579	0.0103	CbGpPWpGaD
Zolpidem—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000576	0.0102	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—TUBB2A—bone cancer	0.000575	0.0102	CbGpPWpGaD
Zolpidem—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000572	0.0101	CbGpPWpGaD
Zolpidem—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000565	0.01	CbGpPWpGaD
Zolpidem—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000535	0.00949	CbGpPWpGaD
Zolpidem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000534	0.00947	CbGpPWpGaD
Zolpidem—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000524	0.00928	CbGpPWpGaD
Zolpidem—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000503	0.00893	CbGpPWpGaD
Zolpidem—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000494	0.00875	CbGpPWpGaD
Zolpidem—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000488	0.00864	CbGpPWpGaD
Zolpidem—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000482	0.00854	CbGpPWpGaD
Zolpidem—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000477	0.00846	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000467	0.00828	CbGpPWpGaD
Zolpidem—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000465	0.00824	CbGpPWpGaD
Zolpidem—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000463	0.00821	CbGpPWpGaD
Zolpidem—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000459	0.00814	CbGpPWpGaD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000457	0.0081	CbGpPWpGaD
Zolpidem—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000444	0.00787	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000429	0.00761	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000426	0.00755	CbGpPWpGaD
Zolpidem—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000425	0.00753	CbGpPWpGaD
Zolpidem—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000419	0.00743	CbGpPWpGaD
Zolpidem—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000408	0.00723	CbGpPWpGaD
Zolpidem—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000392	0.00695	CbGpPWpGaD
Zolpidem—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000389	0.0069	CbGpPWpGaD
Zolpidem—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000384	0.00681	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000364	0.00645	CbGpPWpGaD
Zolpidem—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000359	0.00637	CbGpPWpGaD
Zolpidem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000352	0.00625	CbGpPWpGaD
Zolpidem—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.000348	0.00616	CbGpPWpGaD
Zolpidem—Infestation NOS—Epirubicin—bone cancer	0.000343	0.00139	CcSEcCtD
Zolpidem—Drowsiness—Epirubicin—bone cancer	0.000343	0.00139	CcSEcCtD
Zolpidem—Bronchitis—Doxorubicin—bone cancer	0.000342	0.00139	CcSEcCtD
Zolpidem—Body temperature increased—Cisplatin—bone cancer	0.000337	0.00137	CcSEcCtD
Zolpidem—Neuropathy peripheral—Epirubicin—bone cancer	0.000336	0.00136	CcSEcCtD
Zolpidem—Stomatitis—Epirubicin—bone cancer	0.000334	0.00136	CcSEcCtD
Zolpidem—Urinary tract infection—Epirubicin—bone cancer	0.000333	0.00135	CcSEcCtD
Zolpidem—Conjunctivitis—Epirubicin—bone cancer	0.000333	0.00135	CcSEcCtD
Zolpidem—Dysuria—Doxorubicin—bone cancer	0.000333	0.00135	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000331	0.00134	CcSEcCtD
Zolpidem—Pollakiuria—Doxorubicin—bone cancer	0.000329	0.00133	CcSEcCtD
Zolpidem—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000328	0.00581	CbGpPWpGaD
Zolpidem—Pharyngitis—Methotrexate—bone cancer	0.000326	0.00132	CcSEcCtD
Zolpidem—Urinary tract disorder—Methotrexate—bone cancer	0.000325	0.00132	CcSEcCtD
Zolpidem—Photosensitivity reaction—Doxorubicin—bone cancer	0.000325	0.00132	CcSEcCtD
Zolpidem—Epistaxis—Epirubicin—bone cancer	0.000323	0.00131	CcSEcCtD
Zolpidem—Urethral disorder—Methotrexate—bone cancer	0.000322	0.00131	CcSEcCtD
Zolpidem—Weight decreased—Doxorubicin—bone cancer	0.000322	0.00131	CcSEcCtD
Zolpidem—Sinusitis—Epirubicin—bone cancer	0.000322	0.00131	CcSEcCtD
Zolpidem—Hyperglycaemia—Doxorubicin—bone cancer	0.000321	0.0013	CcSEcCtD
Zolpidem—Pneumonia—Doxorubicin—bone cancer	0.000319	0.00129	CcSEcCtD
Zolpidem—Drowsiness—Doxorubicin—bone cancer	0.000317	0.00129	CcSEcCtD
Zolpidem—Infestation NOS—Doxorubicin—bone cancer	0.000317	0.00129	CcSEcCtD
Zolpidem—Infestation—Doxorubicin—bone cancer	0.000317	0.00129	CcSEcCtD
Zolpidem—Visual impairment—Methotrexate—bone cancer	0.000317	0.00129	CcSEcCtD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000315	0.00559	CbGpPWpGaD
Zolpidem—Hypersensitivity—Cisplatin—bone cancer	0.000314	0.00127	CcSEcCtD
Zolpidem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000312	0.00553	CbGpPWpGaD
Zolpidem—Neuropathy peripheral—Doxorubicin—bone cancer	0.000311	0.00126	CcSEcCtD
Zolpidem—GABRB3—BDNF signaling pathway—EIF2S1—bone cancer	0.000309	0.00548	CbGpPWpGaD
Zolpidem—Stomatitis—Doxorubicin—bone cancer	0.000309	0.00125	CcSEcCtD
Zolpidem—Rhinitis—Epirubicin—bone cancer	0.000309	0.00125	CcSEcCtD
Zolpidem—Urinary tract infection—Doxorubicin—bone cancer	0.000308	0.00125	CcSEcCtD
Zolpidem—Conjunctivitis—Doxorubicin—bone cancer	0.000308	0.00125	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—bone cancer	0.000307	0.00125	CcSEcCtD
Zolpidem—Tinnitus—Methotrexate—bone cancer	0.000307	0.00124	CcSEcCtD
Zolpidem—Hypoaesthesia—Epirubicin—bone cancer	0.000306	0.00124	CcSEcCtD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000306	0.00542	CbGpPWpGaD
Zolpidem—Asthenia—Cisplatin—bone cancer	0.000305	0.00124	CcSEcCtD
Zolpidem—Pharyngitis—Epirubicin—bone cancer	0.000305	0.00124	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—bone cancer	0.000305	0.00124	CcSEcCtD
Zolpidem—Urinary tract disorder—Epirubicin—bone cancer	0.000304	0.00123	CcSEcCtD
Zolpidem—Connective tissue disorder—Epirubicin—bone cancer	0.000302	0.00123	CcSEcCtD
Zolpidem—Urethral disorder—Epirubicin—bone cancer	0.000302	0.00122	CcSEcCtD
Zolpidem—Epistaxis—Doxorubicin—bone cancer	0.000299	0.00121	CcSEcCtD
Zolpidem—Sinusitis—Doxorubicin—bone cancer	0.000298	0.00121	CcSEcCtD
Zolpidem—Visual impairment—Epirubicin—bone cancer	0.000297	0.0012	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—bone cancer	0.000296	0.0012	CcSEcCtD
Zolpidem—Chills—Methotrexate—bone cancer	0.000295	0.0012	CcSEcCtD
Zolpidem—Diarrhoea—Cisplatin—bone cancer	0.000291	0.00118	CcSEcCtD
Zolpidem—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000291	0.00516	CbGpPWpGaD
Zolpidem—Mental disorder—Methotrexate—bone cancer	0.000288	0.00117	CcSEcCtD
Zolpidem—Eye disorder—Epirubicin—bone cancer	0.000288	0.00117	CcSEcCtD
Zolpidem—Tinnitus—Epirubicin—bone cancer	0.000287	0.00116	CcSEcCtD
Zolpidem—Erythema—Methotrexate—bone cancer	0.000286	0.00116	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—bone cancer	0.000286	0.00116	CcSEcCtD
Zolpidem—Flushing—Epirubicin—bone cancer	0.000286	0.00116	CcSEcCtD
Zolpidem—Cardiac disorder—Epirubicin—bone cancer	0.000286	0.00116	CcSEcCtD
Zolpidem—Rhinitis—Doxorubicin—bone cancer	0.000285	0.00116	CcSEcCtD
Zolpidem—Hypoaesthesia—Doxorubicin—bone cancer	0.000283	0.00115	CcSEcCtD
Zolpidem—Pharyngitis—Doxorubicin—bone cancer	0.000283	0.00115	CcSEcCtD
Zolpidem—Urinary tract disorder—Doxorubicin—bone cancer	0.000281	0.00114	CcSEcCtD
Zolpidem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000281	0.00498	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000281	0.00498	CbGpPWpGaD
Zolpidem—Dysgeusia—Methotrexate—bone cancer	0.00028	0.00114	CcSEcCtD
Zolpidem—Connective tissue disorder—Doxorubicin—bone cancer	0.00028	0.00114	CcSEcCtD
Zolpidem—Urethral disorder—Doxorubicin—bone cancer	0.000279	0.00113	CcSEcCtD
Zolpidem—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000277	0.00492	CbGpPWpGaD
Zolpidem—Mediastinal disorder—Epirubicin—bone cancer	0.000277	0.00113	CcSEcCtD
Zolpidem—Back pain—Methotrexate—bone cancer	0.000277	0.00112	CcSEcCtD
Zolpidem—Chills—Epirubicin—bone cancer	0.000276	0.00112	CcSEcCtD
Zolpidem—Arrhythmia—Epirubicin—bone cancer	0.000275	0.00112	CcSEcCtD
Zolpidem—Visual impairment—Doxorubicin—bone cancer	0.000274	0.00111	CcSEcCtD
Zolpidem—Vomiting—Cisplatin—bone cancer	0.000271	0.0011	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—bone cancer	0.00027	0.00109	CcSEcCtD
Zolpidem—Mental disorder—Epirubicin—bone cancer	0.00027	0.00109	CcSEcCtD
Zolpidem—Rash—Cisplatin—bone cancer	0.000268	0.00109	CcSEcCtD
Zolpidem—Dermatitis—Cisplatin—bone cancer	0.000268	0.00109	CcSEcCtD
Zolpidem—Erythema—Epirubicin—bone cancer	0.000268	0.00109	CcSEcCtD
Zolpidem—Malnutrition—Epirubicin—bone cancer	0.000268	0.00109	CcSEcCtD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000267	0.00473	CbGpPWpGaD
Zolpidem—Eye disorder—Doxorubicin—bone cancer	0.000266	0.00108	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—bone cancer	0.000266	0.00108	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—bone cancer	0.000266	0.00108	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—bone cancer	0.000265	0.00107	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—bone cancer	0.000264	0.00107	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—bone cancer	0.000264	0.00107	CcSEcCtD
Zolpidem—Flatulence—Epirubicin—bone cancer	0.000264	0.00107	CcSEcCtD
Zolpidem—Tension—Epirubicin—bone cancer	0.000263	0.00107	CcSEcCtD
Zolpidem—Dysgeusia—Epirubicin—bone cancer	0.000262	0.00106	CcSEcCtD
Zolpidem—Nervousness—Epirubicin—bone cancer	0.00026	0.00106	CcSEcCtD
Zolpidem—Back pain—Epirubicin—bone cancer	0.000259	0.00105	CcSEcCtD
Zolpidem—Malaise—Methotrexate—bone cancer	0.000258	0.00105	CcSEcCtD
Zolpidem—Muscle spasms—Epirubicin—bone cancer	0.000258	0.00105	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—bone cancer	0.000257	0.00104	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—bone cancer	0.000257	0.00104	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—bone cancer	0.000256	0.00104	CcSEcCtD
Zolpidem—Chills—Doxorubicin—bone cancer	0.000256	0.00104	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—bone cancer	0.000254	0.00103	CcSEcCtD
Zolpidem—Nausea—Cisplatin—bone cancer	0.000253	0.00103	CcSEcCtD
Zolpidem—Vision blurred—Epirubicin—bone cancer	0.000252	0.00102	CcSEcCtD
Zolpidem—Cough—Methotrexate—bone cancer	0.00025	0.00101	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—bone cancer	0.000249	0.00101	CcSEcCtD
Zolpidem—Ill-defined disorder—Epirubicin—bone cancer	0.000249	0.00101	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—bone cancer	0.000248	0.00101	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—bone cancer	0.000248	0.00101	CcSEcCtD
Zolpidem—Anaemia—Epirubicin—bone cancer	0.000248	0.001	CcSEcCtD
Zolpidem—Agitation—Epirubicin—bone cancer	0.000246	0.000999	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—bone cancer	0.000244	0.000991	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—bone cancer	0.000244	0.000989	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—bone cancer	0.000244	0.000989	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—bone cancer	0.000244	0.000989	CcSEcCtD
Zolpidem—Tension—Doxorubicin—bone cancer	0.000243	0.000987	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—bone cancer	0.000243	0.000985	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000242	0.000982	CcSEcCtD
Zolpidem—Malaise—Epirubicin—bone cancer	0.000242	0.00098	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—bone cancer	0.000241	0.000977	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—bone cancer	0.000241	0.000977	CcSEcCtD
Zolpidem—Vertigo—Epirubicin—bone cancer	0.000241	0.000977	CcSEcCtD
Zolpidem—Syncope—Epirubicin—bone cancer	0.00024	0.000975	CcSEcCtD
Zolpidem—Leukopenia—Epirubicin—bone cancer	0.00024	0.000973	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—bone cancer	0.00024	0.000973	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—bone cancer	0.000238	0.000967	CcSEcCtD
Zolpidem—Palpitations—Epirubicin—bone cancer	0.000237	0.000961	CcSEcCtD
Zolpidem—Confusional state—Methotrexate—bone cancer	0.000236	0.000956	CcSEcCtD
Zolpidem—Loss of consciousness—Epirubicin—bone cancer	0.000235	0.000956	CcSEcCtD
Zolpidem—Cough—Epirubicin—bone cancer	0.000234	0.000949	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—bone cancer	0.000234	0.000948	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—bone cancer	0.000234	0.000948	CcSEcCtD
Zolpidem—Infection—Methotrexate—bone cancer	0.000232	0.000942	CcSEcCtD
Zolpidem—Hypertension—Epirubicin—bone cancer	0.000231	0.000939	CcSEcCtD
Zolpidem—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00023	0.00408	CbGpPWpGaD
Zolpidem—Ill-defined disorder—Doxorubicin—bone cancer	0.00023	0.000933	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—bone cancer	0.000229	0.00093	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—bone cancer	0.000229	0.00093	CcSEcCtD
Zolpidem—Arthralgia—Epirubicin—bone cancer	0.000228	0.000926	CcSEcCtD
Zolpidem—Chest pain—Epirubicin—bone cancer	0.000228	0.000926	CcSEcCtD
Zolpidem—Myalgia—Epirubicin—bone cancer	0.000228	0.000926	CcSEcCtD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000228	0.00404	CbGpPWpGaD
Zolpidem—Agitation—Doxorubicin—bone cancer	0.000228	0.000924	CcSEcCtD
Zolpidem—Anxiety—Epirubicin—bone cancer	0.000227	0.000922	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—bone cancer	0.000227	0.000921	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000227	0.000919	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—bone cancer	0.000226	0.000917	CcSEcCtD
Zolpidem—Discomfort—Epirubicin—bone cancer	0.000225	0.000915	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—bone cancer	0.000224	0.000907	CcSEcCtD
Zolpidem—Dry mouth—Epirubicin—bone cancer	0.000223	0.000905	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—bone cancer	0.000223	0.000904	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—bone cancer	0.000223	0.000904	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—bone cancer	0.000222	0.000902	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—bone cancer	0.000222	0.0009	CcSEcCtD
Zolpidem—Confusional state—Epirubicin—bone cancer	0.00022	0.000895	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—bone cancer	0.000219	0.000889	CcSEcCtD
Zolpidem—Oedema—Epirubicin—bone cancer	0.000219	0.000887	CcSEcCtD
Zolpidem—Anaphylactic shock—Epirubicin—bone cancer	0.000219	0.000887	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—bone cancer	0.000218	0.000886	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—bone cancer	0.000218	0.000884	CcSEcCtD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000217	0.00385	CbGpPWpGaD
Zolpidem—Infection—Epirubicin—bone cancer	0.000217	0.000882	CcSEcCtD
Zolpidem—Cough—Doxorubicin—bone cancer	0.000216	0.000878	CcSEcCtD
Zolpidem—Shock—Epirubicin—bone cancer	0.000215	0.000873	CcSEcCtD
Zolpidem—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000215	0.0038	CbGpPWpGaD
Zolpidem—Nervous system disorder—Epirubicin—bone cancer	0.000214	0.00087	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—bone cancer	0.000214	0.000869	CcSEcCtD
Zolpidem—Tachycardia—Epirubicin—bone cancer	0.000213	0.000866	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000213	0.000864	CcSEcCtD
Zolpidem—Skin disorder—Epirubicin—bone cancer	0.000212	0.000862	CcSEcCtD
Zolpidem—Hyperhidrosis—Epirubicin—bone cancer	0.000211	0.000858	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—bone cancer	0.000211	0.000858	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—bone cancer	0.000211	0.000856	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—bone cancer	0.000211	0.000856	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—bone cancer	0.000211	0.000856	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—bone cancer	0.00021	0.000853	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—bone cancer	0.00021	0.000851	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00021	0.000851	CcSEcCtD
Zolpidem—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.00021	0.00371	CbGpPWpGaD
Zolpidem—Discomfort—Doxorubicin—bone cancer	0.000209	0.000846	CcSEcCtD
Zolpidem—Anorexia—Epirubicin—bone cancer	0.000208	0.000846	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—bone cancer	0.000208	0.000845	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—bone cancer	0.000208	0.000843	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—bone cancer	0.000206	0.000838	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—bone cancer	0.000206	0.000835	CcSEcCtD
Zolpidem—Hypotension—Epirubicin—bone cancer	0.000204	0.000829	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—bone cancer	0.000204	0.000828	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—bone cancer	0.000203	0.000824	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—bone cancer	0.000202	0.000821	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—bone cancer	0.000202	0.000821	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—bone cancer	0.000202	0.000819	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—bone cancer	0.000201	0.000817	CcSEcCtD
Zolpidem—Infection—Doxorubicin—bone cancer	0.000201	0.000816	CcSEcCtD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.0002	0.00354	CbGpPWpGaD
Zolpidem—Pain—Methotrexate—bone cancer	0.0002	0.000811	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000199	0.000808	CcSEcCtD
Zolpidem—Shock—Doxorubicin—bone cancer	0.000199	0.000808	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—bone cancer	0.000198	0.000805	CcSEcCtD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000198	0.00351	CbGpPWpGaD
Zolpidem—Insomnia—Epirubicin—bone cancer	0.000198	0.000803	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—bone cancer	0.000197	0.000801	CcSEcCtD
Zolpidem—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000197	0.0035	CbGpPWpGaD
Zolpidem—Skin disorder—Doxorubicin—bone cancer	0.000197	0.000797	CcSEcCtD
Zolpidem—Paraesthesia—Epirubicin—bone cancer	0.000196	0.000797	CcSEcCtD
Zolpidem—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000196	0.00347	CbGpPWpGaD
Zolpidem—Hyperhidrosis—Doxorubicin—bone cancer	0.000196	0.000794	CcSEcCtD
Zolpidem—Dyspnoea—Epirubicin—bone cancer	0.000195	0.000791	CcSEcCtD
Zolpidem—Somnolence—Epirubicin—bone cancer	0.000194	0.000789	CcSEcCtD
Zolpidem—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000193	0.00343	CbGpPWpGaD
Zolpidem—Anorexia—Doxorubicin—bone cancer	0.000193	0.000783	CcSEcCtD
Zolpidem—Feeling abnormal—Methotrexate—bone cancer	0.000193	0.000781	CcSEcCtD
Zolpidem—Dyspepsia—Epirubicin—bone cancer	0.000192	0.000781	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—bone cancer	0.000191	0.000775	CcSEcCtD
Zolpidem—Decreased appetite—Epirubicin—bone cancer	0.00019	0.000771	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—bone cancer	0.000189	0.000767	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Epirubicin—bone cancer	0.000189	0.000766	CcSEcCtD
Zolpidem—Fatigue—Epirubicin—bone cancer	0.000189	0.000765	CcSEcCtD
Zolpidem—Pain—Epirubicin—bone cancer	0.000187	0.000759	CcSEcCtD
Zolpidem—Constipation—Epirubicin—bone cancer	0.000187	0.000759	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—bone cancer	0.000186	0.000753	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—bone cancer	0.000185	0.00075	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—bone cancer	0.000185	0.00075	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000184	0.000748	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—bone cancer	0.000183	0.000743	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—bone cancer	0.000182	0.000737	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—bone cancer	0.00018	0.000732	CcSEcCtD
Zolpidem—Feeling abnormal—Epirubicin—bone cancer	0.00018	0.000731	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—bone cancer	0.00018	0.00073	CcSEcCtD
Zolpidem—Gastrointestinal pain—Epirubicin—bone cancer	0.000179	0.000726	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—bone cancer	0.000178	0.000723	CcSEcCtD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000176	0.00312	CbGpPWpGaD
Zolpidem—Decreased appetite—Doxorubicin—bone cancer	0.000176	0.000714	CcSEcCtD
Zolpidem—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000175	0.0031	CbGpPWpGaD
Zolpidem—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000175	0.000709	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—bone cancer	0.000174	0.000708	CcSEcCtD
Zolpidem—Urticaria—Epirubicin—bone cancer	0.000174	0.000705	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—bone cancer	0.000173	0.000702	CcSEcCtD
Zolpidem—Pain—Doxorubicin—bone cancer	0.000173	0.000702	CcSEcCtD
Zolpidem—Abdominal pain—Epirubicin—bone cancer	0.000173	0.000701	CcSEcCtD
Zolpidem—Body temperature increased—Epirubicin—bone cancer	0.000173	0.000701	CcSEcCtD
Zolpidem—Hypersensitivity—Methotrexate—bone cancer	0.000172	0.000699	CcSEcCtD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000169	0.003	CbGpPWpGaD
Zolpidem—Asthenia—Methotrexate—bone cancer	0.000168	0.00068	CcSEcCtD
Zolpidem—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000168	0.00297	CbGpPWpGaD
Zolpidem—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000167	0.00296	CbGpPWpGaD
Zolpidem—Feeling abnormal—Doxorubicin—bone cancer	0.000167	0.000677	CcSEcCtD
Zolpidem—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000167	0.00295	CbGpPWpGaD
Zolpidem—Gastrointestinal pain—Doxorubicin—bone cancer	0.000165	0.000671	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—bone cancer	0.000165	0.000671	CcSEcCtD
Zolpidem—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000165	0.00293	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000164	0.0029	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000163	0.00288	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000162	0.00288	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000162	0.00287	CbGpPWpGaD
Zolpidem—Hypersensitivity—Epirubicin—bone cancer	0.000161	0.000654	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—bone cancer	0.000161	0.000652	CcSEcCtD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000161	0.00285	CbGpPWpGaD
Zolpidem—Body temperature increased—Doxorubicin—bone cancer	0.00016	0.000649	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—bone cancer	0.00016	0.000649	CcSEcCtD
Zolpidem—Diarrhoea—Methotrexate—bone cancer	0.00016	0.000649	CcSEcCtD
Zolpidem—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00016	0.00283	CbGpPWpGaD
Zolpidem—Asthenia—Epirubicin—bone cancer	0.000157	0.000637	CcSEcCtD
Zolpidem—Pruritus—Epirubicin—bone cancer	0.000155	0.000628	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—bone cancer	0.000155	0.000627	CcSEcCtD
Zolpidem—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000151	0.00267	CbGpPWpGaD
Zolpidem—Diarrhoea—Epirubicin—bone cancer	0.00015	0.000607	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—bone cancer	0.000149	0.000605	CcSEcCtD
Zolpidem—Vomiting—Methotrexate—bone cancer	0.000149	0.000603	CcSEcCtD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000147	0.00261	CbGpPWpGaD
Zolpidem—Rash—Methotrexate—bone cancer	0.000147	0.000598	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—bone cancer	0.000147	0.000597	CcSEcCtD
Zolpidem—Headache—Methotrexate—bone cancer	0.000146	0.000594	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—bone cancer	0.000145	0.000589	CcSEcCtD
Zolpidem—Dizziness—Epirubicin—bone cancer	0.000145	0.000587	CcSEcCtD
Zolpidem—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000144	0.00255	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000143	0.00254	CbGpPWpGaD
Zolpidem—Pruritus—Doxorubicin—bone cancer	0.000143	0.000581	CcSEcCtD
Zolpidem—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000141	0.00251	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000141	0.0025	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000141	0.00249	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00014	0.00249	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00014	0.00248	CbGpPWpGaD
Zolpidem—Vomiting—Epirubicin—bone cancer	0.000139	0.000564	CcSEcCtD
Zolpidem—PTGS1—Biological oxidations—GSTP1—bone cancer	0.000139	0.00246	CbGpPWpGaD
Zolpidem—Nausea—Methotrexate—bone cancer	0.000139	0.000563	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—bone cancer	0.000138	0.000562	CcSEcCtD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000138	0.00245	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000138	0.00245	CbGpPWpGaD
Zolpidem—Rash—Epirubicin—bone cancer	0.000138	0.000559	CcSEcCtD
Zolpidem—Dermatitis—Epirubicin—bone cancer	0.000138	0.000559	CcSEcCtD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000137	0.00243	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000137	0.00243	CbGpPWpGaD
Zolpidem—Headache—Epirubicin—bone cancer	0.000137	0.000556	CcSEcCtD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000135	0.00239	CbGpPWpGaD
Zolpidem—Dizziness—Doxorubicin—bone cancer	0.000134	0.000543	CcSEcCtD
Zolpidem—Nausea—Epirubicin—bone cancer	0.00013	0.000527	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—bone cancer	0.000129	0.000522	CcSEcCtD
Zolpidem—Rash—Doxorubicin—bone cancer	0.000128	0.000518	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—bone cancer	0.000127	0.000517	CcSEcCtD
Zolpidem—Headache—Doxorubicin—bone cancer	0.000127	0.000514	CcSEcCtD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000123	0.00219	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	0.000123	0.00218	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000121	0.00215	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000121	0.00214	CbGpPWpGaD
Zolpidem—Nausea—Doxorubicin—bone cancer	0.00012	0.000488	CcSEcCtD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000119	0.00212	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000118	0.00209	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000118	0.00209	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000116	0.00205	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000115	0.00204	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000113	0.002	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000113	0.002	CbGpPWpGaD
Zolpidem—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000111	0.00198	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000111	0.00196	CbGpPWpGaD
Zolpidem—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000107	0.00189	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000106	0.00187	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000104	0.00184	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—GSTP1—bone cancer	0.000104	0.00184	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000103	0.00183	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	0.000102	0.00181	CbGpPWpGaD
Zolpidem—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000102	0.0018	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000101	0.0018	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NDUFA12—bone cancer	0.0001	0.00178	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	9.87e-05	0.00175	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—JUN—bone cancer	9.77e-05	0.00173	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NDUFA12—bone cancer	9.73e-05	0.00173	CbGpPWpGaD
Zolpidem—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	9.63e-05	0.00171	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP3A4—bone cancer	9.36e-05	0.00166	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	9.28e-05	0.00165	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	9.28e-05	0.00165	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	9.23e-05	0.00164	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	8.86e-05	0.00157	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	8.86e-05	0.00157	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	8.7e-05	0.00154	CbGpPWpGaD
Zolpidem—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	8.68e-05	0.00154	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	8.65e-05	0.00153	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP3A4—bone cancer	8.61e-05	0.00153	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP3A4—bone cancer	8.54e-05	0.00151	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	8.49e-05	0.00151	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	8.49e-05	0.00151	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—BRAF—bone cancer	8.49e-05	0.0015	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	8.42e-05	0.00149	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	8.37e-05	0.00148	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NT5C3A—bone cancer	8.32e-05	0.00147	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—BRAF—bone cancer	8.1e-05	0.00144	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NT5C3A—bone cancer	8.06e-05	0.00143	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.01e-05	0.00142	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—BRAF—bone cancer	7.96e-05	0.00141	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—BRAF—bone cancer	7.91e-05	0.0014	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	7.9e-05	0.0014	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	7.87e-05	0.00139	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—BRAF—bone cancer	7.76e-05	0.00138	CbGpPWpGaD
Zolpidem—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.43e-05	0.00132	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	7.42e-05	0.00132	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—GSTP1—bone cancer	7.36e-05	0.00131	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.3e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP3A4—bone cancer	7.29e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	7.26e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NDUFA12—bone cancer	7.26e-05	0.00129	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	7.2e-05	0.00128	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.19e-05	0.00128	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—MDM2—bone cancer	7.11e-05	0.00126	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—BRAF—bone cancer	6.79e-05	0.0012	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—MDM2—bone cancer	6.79e-05	0.0012	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—MDM2—bone cancer	6.67e-05	0.00118	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—MDM2—bone cancer	6.62e-05	0.00117	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	6.58e-05	0.00117	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	6.58e-05	0.00117	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—MDM2—bone cancer	6.51e-05	0.00115	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.24e-05	0.00111	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.15e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NT5C3A—bone cancer	6.01e-05	0.00107	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—MDM2—bone cancer	5.69e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NDUFA12—bone cancer	5.61e-05	0.000995	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NDUFA12—bone cancer	5.16e-05	0.000915	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NDUFA12—bone cancer	5.12e-05	0.000907	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.81e-05	0.000853	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.75e-05	0.000842	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NT5C3A—bone cancer	4.65e-05	0.000824	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NDUFA12—bone cancer	4.37e-05	0.000775	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NT5C3A—bone cancer	4.28e-05	0.000758	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NT5C3A—bone cancer	4.24e-05	0.000752	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ENO2—bone cancer	3.64e-05	0.000646	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NT5C3A—bone cancer	3.62e-05	0.000642	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ENO2—bone cancer	3.53e-05	0.000626	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—DHFR—bone cancer	3.38e-05	0.000599	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NDUFA12—bone cancer	3.37e-05	0.000598	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—DHFR—bone cancer	3.28e-05	0.000581	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GNA11—bone cancer	3.16e-05	0.00056	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GNA11—bone cancer	3.06e-05	0.000543	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP3A4—bone cancer	2.86e-05	0.000508	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NT5C3A—bone cancer	2.8e-05	0.000496	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP3A4—bone cancer	2.78e-05	0.000492	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.76e-05	0.00049	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ENO2—bone cancer	2.63e-05	0.000467	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTP1—bone cancer	2.45e-05	0.000434	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—DHFR—bone cancer	2.44e-05	0.000433	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTP1—bone cancer	2.37e-05	0.000421	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GNA11—bone cancer	2.28e-05	0.000405	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP3A4—bone cancer	2.07e-05	0.000367	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ENO2—bone cancer	2.04e-05	0.000361	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—DHFR—bone cancer	1.89e-05	0.000335	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ENO2—bone cancer	1.87e-05	0.000332	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ENO2—bone cancer	1.86e-05	0.000329	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTP1—bone cancer	1.77e-05	0.000314	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GNA11—bone cancer	1.77e-05	0.000313	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—DHFR—bone cancer	1.74e-05	0.000308	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—DHFR—bone cancer	1.72e-05	0.000305	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GNA11—bone cancer	1.62e-05	0.000288	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GNA11—bone cancer	1.61e-05	0.000285	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP3A4—bone cancer	1.6e-05	0.000284	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.59e-05	0.000282	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ENO2—bone cancer	1.59e-05	0.000281	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP3A4—bone cancer	1.47e-05	0.000261	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—DHFR—bone cancer	1.47e-05	0.000261	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP3A4—bone cancer	1.46e-05	0.000259	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.45e-05	0.000257	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GNA11—bone cancer	1.38e-05	0.000244	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTP1—bone cancer	1.37e-05	0.000243	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS2—bone cancer	1.27e-05	0.000225	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTP1—bone cancer	1.26e-05	0.000223	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTP1—bone cancer	1.25e-05	0.000221	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP3A4—bone cancer	1.25e-05	0.000221	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.24e-05	0.00022	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTGS2—bone cancer	1.23e-05	0.000218	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ENO2—bone cancer	1.22e-05	0.000217	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—DHFR—bone cancer	1.14e-05	0.000201	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTP1—bone cancer	1.07e-05	0.000189	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GNA11—bone cancer	1.06e-05	0.000188	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS2—bone cancer	9.18e-06	0.000163	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTP1—bone cancer	8.23e-06	0.000146	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS2—bone cancer	7.09e-06	0.000126	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS2—bone cancer	6.52e-06	0.000116	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS2—bone cancer	6.47e-06	0.000115	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS2—bone cancer	5.53e-06	9.8e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS2—bone cancer	4.27e-06	7.56e-05	CbGpPWpGaD
